39
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

Histamine H4 antagonists

Pages 1641-1644 | Published online: 25 Feb 2005

Bibliography

  • ARRANG JM, GARBARG M, SCHWARTZ JC: Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature (1983) 302:832–837.
  • NAKAMURA T, ITADANI H, HIDAKA Yet al.: Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Commun. (2000) 279:615–620.
  • LIU C, MAX, JIANG X et al.: Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow Mol. Pharmacol (2001) 59:420–426.
  • LIU C, WILSON SJ, KUEI C, LOVENBERG TW: Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. Pharmacol Exp. Thar. (2001) 299:121–130.
  • HASHIMOTO T, HARUSAWA S, ARAKI L et at A selective human H4-receptor agonist: 02 cyano 1 [111-imidazol-4(5)-yl]tetrahydrofurari-2-y]etrahydrofuran-2-yl methylguanidine. J. Med. Chem. (2003) 46(14):3162–3165.
  • JABLONOWSKI JA, GRICE CA, CHAT W et al The first potent and selective non-imidazole human histamine H4 receptor antagonists. J. Med. Chem. (2003) 46(19):3957–3960.
  • TAKESHITA K, SAKAI K, BACON KB, GANTNER F: Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. Pharmacol Exp. The]: (2003) 307:1072–1078
  • THURMOND RL, DESAI PJ, DUNFORD PJ et al.: A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. I Pharmacol Exp. The]: (2004) 309:404–413.
  • LING P, NGO K, NGUYEN S et a/. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. BE J. Pharmacol (2004) 142:61–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.